Item 5. Market for Registrant’s Common Equity
ITEM 5.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
The common shares of the Company are traded on The NASDAQ Capital Market under the symbol “FCAP.” As of December 31, 2025, the Company had 831 stockholders of record and 3,341,871 common shares outstanding. This does not reflect the number of persons whose shares are in nominee or “street” name accounts through brokers. See Note 17 in the accompanying Notes to Consolidated Financial Statements for information regarding dividend restrictions applicable to the Company.
The following table lists quarterly market price and dividend information per common share for the years ended December 31, 2025 and 2024 as reported by NASDAQ.
Market Price
High Sale
Low Sale
Dividends
End of Period
2025:
First Quarter
$
39.40
$
30.49
$
0.29
$
38.15
Second Quarter
53.85
37.53
0.29
41.29
Third Quarter
46.52
33.73
0.31
45.80
Fourth Quarter
71.00
37.64
0.31
59.20
2024:
First Quarter
$
30.40
$
26.03
$
0.27
$
28.55
Second Quarter
31.40
26.73
0.27
29.99
Third Quarter
38.00
29.01
0.29
34.96
Fourth Quarter
37.50
28.50
0.29
32.25
Dividend Policy
It has been our policy to pay quarterly dividends to holders of our common stock, and we intend to continue paying dividends. Our dividend policy and practice may change in the future, however, and our Board of Directors may change or eliminate the payment of future dividends at its discretion, without notice to our shareholders. Any future determination to pay dividends to holders of our common stock will depend on our results of operations, financial condition, capital requirements, banking regulations, contractual restrictions and any other factors that our Board of Directors may deem relevant.
38
Table of Contents
Repurchases of Equity Securities
On August 19, 2008, the Board of Directors authorized the repurchase of up to 240,467 shares of the Company’s outstanding common stock. The stock repurchase program will expire upon the purchase of the maximum number of shares authorized under the program, unless the Board of Directors terminates the program earlier. There were 12,039 shares purchased under the stock repurchase program during the quarter ended December 31, 2025. The maximum number of shares that may yet be purchased under the plan is 99,989.
(c) Total Number of
(d) Maximum
Shares Purchased as
Number of Shares
Part of Publicly
that May Yet Be
(a) Total Number of
(b) Average Price
Announced Plans or
Purchased Under the
Period
Shares Purchased
Paid Per Share
Programs
Plans or Programs
October 1 through October 31, 2025
6,283
$
41.55
6,283
105,745
November 1 through November 31, 2025
5,652
45.09
5,652
100,093
December 1 through December 31, 2025
104
65.00
104
99,989
Total
12,039
$
43.42
12,039
On August 29, 2025, the Company entered into a Joint Rule 10b5-1/Rule 10b-18 Plan Agreement (the “10b5-1 Plan”) under which the Company’s designated broker has the authority to repurchase up to 113,236 shares of common stock of the Company. The Plan commenced on September 4, 2025, and expires on August 28, 2026. The Plan was established in connection with the Company’s previously disclosed stock repurchase authorization, which was approved by the Company’s Board of Directors on August 19, 2008. The purchases disclosed in the table above were pursuant to the terms of the 10b5-1 Plan.
Sales of Unregistered Equity Securities
There were no sales of unregistered Company securities sold by the Company in the years 2023, 2024, or 2025.
Equity Compensation Plan Information
See Item 12 of this report for disclosure regarding securities authorized for issuance and equity compensation plans required by Item 201(d) of Regulation S-K.
ITEM 6.
[ RESERVED]
39
Table of Contents